If any controlled substance appears in the listed bulk database, please ignore it, as we do not supply or offer controlled substances.
Alogliptin N-Acetylated Metabolite M-II
100% accuracy
of data
24/7 scientific
support
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

2882929-91-9Alogliptin N-Acetylated Metabolite M-II

● In Stock

Catalogue No.:VL5900009
CAS No.:2882929-91-9
Mol. Formula:C19H21N5O3
Mol. Weight:367.41 g/mol

Additional information on CAS 2882929-91-9

Parent drug

Alogliptin

IUPAC Name

(R)-2-((3-acetyl-6-(3-aminopiperidin-1-yl)-2, 4-dioxo-3, 4-dihydropyrimidin-1(2H)-yl)methyl)benzonitrile

Synonyms

N/A

Description

Alogliptin N Acetylated Metabolite M II or (R)-2-((3-acetyl-6-(3-aminopiperidin-1-yl)-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzonitrile, it is a selective, dipeptidyl peptidase-4 inhibitor that is used to treat hyperglycemia in patients with type 2 diabetes mellitus.

References

Dineen, Laura, et al. “Alogliptin (Nesina) for Adults with Type-2 Diabetes.” Pharmacy and Therapeutics, vol. 39, no. 3, 1 Mar. 2014, pp. 186–202, www.ncbi.nlm.nih.gov/pmc/articles/PMC4005122/.

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
This field is hidden when viewing the form
Products quotation
Name
Url
 
This field is hidden when viewing the form
This field is hidden when viewing the form